Department of Neuroscience and Experimental Therapeutics, College of Medicine, Texas A&M Health Science Center, 228 Reynolds Medical Bldg., College Station, TX 77843-1114, USA.
J Pharmacol Exp Ther. 2010 Sep 1;334(3):1031-41. doi: 10.1124/jpet.110.169854. Epub 2010 Jun 15.
Testosterone modulates seizure susceptibility, but the underlying mechanisms are obscure. Recently, we demonstrated that testosterone affects seizure activity via its conversion to neurosteroids in the brain. Androstanediol (5alpha-androstan-3alpha,17beta-diol) is an endogenous neurosteroid synthesized from testosterone. However, the molecular mechanism underlying the seizure protection activity of androstanediol remains unclear. Here, we show that androstanediol has positive allosteric activity as a GABA(A) receptor modulator. In whole-cell recordings from acutely dissociated hippocampus CA1 pyramidal cells, androstanediol (but not its 3beta-epimer) produced a concentration-dependent enhancement of GABA-activated currents (EC(50) of 5 microM). At 1 microM, androstanediol produced a 50% potentiation of GABA responses. In the absence of GABA, androstanediol has moderate direct effects on GABA(A) receptor-mediated currents at high concentrations. Systemic doses of androstanediol (5-100 mg/kg), but not its 3beta-epimer, caused dose-dependent suppression of behavioral and electrographic seizures in mouse hippocampus kindling, which is a model of temporal lobe epilepsy. The ED(50) value for antiseizure effects of androstanediol was 50 mg/kg, which did not produce sedation/motor toxicity. At high (2x ED(50)) doses, androstanediol produced complete seizure protection that lasted for up to 3 h after injection. The estimated plasma concentrations of androstanediol producing 50% seizure protection in the kindling model (10.6 microM) are within the range of concentrations that modulate GABA(A) receptors. These studies suggest that androstanediol could be a neurosteroid mediator of testosterone actions on neuronal excitability and seizure susceptibility via its activity as a GABA(A) receptor modulator and that androstanediol may play a key role in men with epilepsy, especially during the age-related decline in androgen levels.
睾酮调节癫痫易感性,但潜在机制尚不清楚。最近,我们证明睾酮通过在大脑中转化为神经甾体来影响癫痫活动。雄烷二醇(5α-雄烷-3α,17β-二醇)是一种从睾酮合成的内源性神经甾体。然而,雄烷二醇的抗癫痫作用的分子机制尚不清楚。在这里,我们表明雄烷二醇具有作为 GABA(A) 受体调节剂的正变构活性。在急性分离的海马 CA1 锥体神经元的全细胞膜片钳记录中,雄烷二醇(但不是其 3β-差向异构体)产生 GABA 激活电流的浓度依赖性增强(EC50 为 5 μM)。在 1 μM 时,雄烷二醇产生 GABA 反应的 50%增强。在没有 GABA 的情况下,雄烷二醇在高浓度下对 GABA(A) 受体介导的电流具有适度的直接作用。系统给予雄烷二醇(5-100mg/kg),但不是其 3β-差向异构体,导致小鼠海马点燃模型中行为和脑电图癫痫发作的剂量依赖性抑制,这是颞叶癫痫的模型。雄烷二醇抗癫痫作用的 ED50 值为 50mg/kg,不会产生镇静/运动毒性。在高(2x ED50)剂量下,雄烷二醇产生完全的癫痫保护,在注射后长达 3 小时内持续。在点燃模型中产生 50%癫痫保护的雄烷二醇的估计血浆浓度(10.6μM)在调节 GABA(A) 受体的浓度范围内。这些研究表明,雄烷二醇可能是睾酮对神经元兴奋性和癫痫易感性作用的神经甾体介质,通过其作为 GABA(A) 受体调节剂的活性,以及在癫痫男性中,特别是在与年龄相关的雄激素水平下降期间,雄烷二醇可能发挥关键作用。